Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Labcorp's Chief Marketing Officer sold $136K of Labcorp shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Planned for Nov 10, 2026 · Notice filed Nov 10, 2026
A Labcorp officer told the SEC about a plan to sell $744K of Labcorp shares around Nov 10, 2026. The filing says the shares were acquired as compensation.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Labcorp's Chief Marketing Officer sold $136K of Labcorp shares. The filing does not indicate a pre-arranged trading plan.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Amy B. Summy (Officer) plans to sell ~$136K of Labcorp
Planned, from payEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: reported its results, 13 days earlier (Oct 28, 2026).